HighTower Advisors’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $767K | Sell |
1,646
-233
| -12% | -$98K | ﹤0.01% | 2410 |
|
|
2026
Q1 | $709K | Sell |
1,879
-512
| -21% | -$219K | ﹤0.01% | 2430 |
|
|
2025
Q4 | $1.02M | Sell |
2,391
-317
| -12% | -$138K | ﹤0.01% | 2093 |
|
|
2025
Q3 | $1.21M | Buy |
2,708
+371
| +16% | +$168K | ﹤0.01% | 1967 |
|
|
2025
Q2 | $1.14M | Sell |
2,337
-115
| -5% | -$65.5K | ﹤0.01% | 1930 |
|
|
2025
Q1 | $1.51M | Buy |
2,452
+145
| +6% | +$82.4K | ﹤0.01% | 1690 |
|
|
2024
Q4 | $1.22M | Sell |
2,307
-1,423
| -38% | -$802K | ﹤0.01% | 1830 |
|
|
2024
Q3 | $2.25M | Buy |
3,730
+1,634
| +78% | +$926K | ﹤0.01% | 1451 |
|
|
2024
Q2 | $1.17M | Sell |
2,096
-93
| -4% | -$53.3K | ﹤0.01% | 1758 |
|
|
2024
Q1 | $1.41M | Sell |
2,189
-21
| -1% | -$12.8K | ﹤0.01% | 1606 |
|
|
2023
Q4 | $1.31M | Buy |
2,210
+274
| +14% | +$153K | ﹤0.01% | 1694 |
|
|
2023
Q3 | $1.05M | Buy |
1,936
+8
| +0.4% | +$4.16K | ﹤0.01% | 1741 |
|
|
2023
Q2 | $1.07M | Buy |
1,928
+259
| +16% | +$142K | ﹤0.01% | 1713 |
|
|
2023
Q1 | $920K | Buy |
1,669
+112
| +7% | +$57.1K | ﹤0.01% | 1715 |
|
|
2022
Q4 | $829K | Buy |
1,557
+649
| +71% | +$316K | ﹤0.01% | 1782 |
|
|
2022
Q3 | $393K | Buy |
908
+43
| +5% | +$20.7K | ﹤0.01% | 2180 |
|
|
2022
Q2 | $402K | Buy |
865
+29
| +3% | +$14.1K | ﹤0.01% | 2176 |
|
|
2022
Q1 | $432K | Buy |
836
+49
| +6% | +$23.5K | ﹤0.01% | 2278 |
|
|
2021
Q4 | $421K | Sell |
787
-84
| -10% | -$40.3K | ﹤0.01% | 2263 |
|
|
2021
Q3 | $402K | Sell |
871
-1,105
| -56% | -$521K | ﹤0.01% | 2211 |
|
|
2021
Q2 | $909K | Sell |
1,976
-98
| -5% | -$47.1K | ﹤0.01% | 1690 |
|
|
2021
Q1 | $939K | Sell |
2,074
-509
| -20% | -$250K | ﹤0.01% | 1602 |
|
|
2020
Q4 | $1.39M | Buy |
2,583
+137
| +6% | +$67.3K | 0.01% | 1090 |
|
|
2020
Q3 | $1.16M | Buy |
2,446
+91
| +4% | +$44.6K | 0.01% | 1140 |
|
|
2020
Q2 | $1.06M | Buy |
2,355
+297
| +14% | +$133K | 0.01% | 1085 |
|
|
2020
Q1 | $886K | Sell |
2,058
-512
| -20% | -$229K | 0.01% | 1067 |
|
|
2019
Q4 | $1.13M | Buy |
2,570
+167
| +7% | +$70.3K | 0.01% | 1085 |
|
|
2019
Q3 | $1.01M | Buy |
2,403
+389
| +19% | +$159K | 0.01% | 1178 |
|
|
2019
Q2 | $719K | Buy |
2,014
+478
| +31% | +$160K | ﹤0.01% | 1344 |
|
|
2019
Q1 | $492K | Buy |
1,536
+175
| +13% | +$53.7K | ﹤0.01% | 1468 |
|
|
2018
Q4 | $381K | Buy |
1,361
+210
| +18% | +$63.4K | ﹤0.01% | 1492 |
|
|
2018
Q3 | $370K | Buy |
1,151
+434
| +61% | +$138K | ﹤0.01% | 1617 |
|
|
2018
Q2 | $230K | Buy |
+717
| New | +$224K | ﹤0.01% | 1827 |
|
|
2016
Q3 | – | Sell |
-11,602
| Closed | -$1.58M | – | 1885 |
|
|
2016
Q2 | $1.58M | Sell |
11,602
-1,832
| -14% | -$243K | 0.02% | 702 |
|
|
2016
Q1 | $1.82M | Sell |
13,434
-3,040
| -18% | -$411K | 0.01% | 760 |
|
|
2015
Q4 | $2.46M | Buy |
16,474
+1,322
| +9% | +$195K | 0.03% | 554 |
|
|
2015
Q3 | $2.02M | Buy |
+15,152
| New | +$2.12M | 0.03% | 614 |
|
Other funds holding CHE
EIP
HighTower Advisors's CHE Position: Q2 2026 in Review
HighTower Advisors reduced its Chemed (CHE) stake by 12% in Q2 2026, selling an estimated $98K and leaving 1,646 shares worth $767K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.
HighTower Advisors first reported a position in CHE in Q3 2015 and has held it in 37 quarters since. The position peaked at $2.46M in Q4 2015. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- HighTower Advisors held 1,646 shares of Chemed worth $767K as of Q2 2026.
- HighTower Advisors sold 233 Chemed shares in Q2 2026, an estimated $98K.
- Chemed made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2410 holding.
- HighTower Advisors first reported a position in Chemed in Q3 2015 and has held it in 37 quarters since.
- HighTower Advisors's Chemed position peaked at $2.46M in Q4 2015.
- 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.